A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
Virogen Biotechnology Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
National Cancer Institute (NCI)
Mayo Clinic
University of Alabama at Birmingham
Bristol-Myers Squibb
Memorial Sloan Kettering Cancer Center
Soligenix
Prescient Therapeutics, Ltd.
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Washington University School of Medicine
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Kasr El Aini Hospital
Institute of Hematology & Blood Diseases Hospital, China
National Cancer Institute (NCI)
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
M.D. Anderson Cancer Center
Kyowa Kirin Co., Ltd.
Columbia University
SciTech Development, Inc.
City of Hope Medical Center
Mayo Clinic
Soligenix
Icahn School of Medicine at Mount Sinai
Barbara Ann Karmanos Cancer Institute
Stanford University
AHS Cancer Control Alberta
City of Hope Medical Center
City of Hope Medical Center
Mayo Clinic
Thomas Jefferson University
Thomas Jefferson University
University College, London
Innate Pharma
4SC AG
Emory University
University of Pittsburgh
Indiana University